A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection
Description
The respiratory system, especially the lung, is the key site of pathological injury induced by SARS-CoV-2 infection. Given the low feasibility of targeted delivery of antibodies into the lungs by intravenous administration and the short half-life
